Cargando…

Brain-penetrant heat shock protein amplifier arimoclomol enhances GCase activity in in vitro Gaucher disease models

Detalles Bibliográficos
Autores principales:	Hettinghouse, Aubryanna, Liu, Chuan-ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306393/ https://www.ncbi.nlm.nih.gov/pubmed/30522930 http://dx.doi.org/10.1016/j.ebiom.2018.11.052

Ejemplares similares

The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase
por: Fog, Cathrine K., et al.
Publicado: (2018)

GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
por: Martínez-Bailén, Macarena, et al.
Publicado: (2022)

The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa
por: Parfitt, D A, et al.
Publicado: (2014)

Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes
por: Jian, Jinlong, et al.
Publicado: (2017)

Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease
por: Jian, Jinlong, et al.
Publicado: (2016)

3,4,5‐Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers
por: Vanni, Costanza, et al.
Publicado: (2022)

FYCO1 Increase and Effect of Arimoclomol–Treatment in Human VCP–Pathology
por: Guettsches, Anne-Katrin, et al.
Publicado: (2022)

Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models
por: Kuta, Rachel, et al.
Publicado: (2020)

Atsttrin Promotes Cartilage Repair Primarily Through TNFR2-Akt Pathway
por: Wei, Jianlu, et al.
Publicado: (2020)

Animal models for Gaucher disease research
por: Farfel-Becker, Tamar, et al.
Publicado: (2011)

GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice
por: van der Lienden, Martijn J. C., et al.
Publicado: (2021)

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker Discovery
por: Esfandiary, Ali, et al.
Publicado: (2022)

Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
por: Benatar, Michael, et al.
Publicado: (2018)

Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice
por: Zhao, Xiangli, et al.
Publicado: (2021)

Progranulin as a Novel Factor in Gaucher Disease
por: Choy, Francis Y.M., et al.
Publicado: (2016)

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
por: Oftedal, Linn, et al.
Publicado: (2023)

A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease
por: Fujii, Takahiro, et al.
Publicado: (2021)

RNA-Seq analysis of interferon inducible p204-mediated network in anti-tumor immunity
por: Jian, Jinlong, et al.
Publicado: (2018)

Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)
por: Clemente, Francesca, et al.
Publicado: (2021)

Progranulin derivative Atsttrin protects against early osteoarthritis in mouse and rat models
por: Wei, Jian-lu, et al.
Publicado: (2017)

The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease
por: Drelichman, Guillermo, et al.
Publicado: (2019)

Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown
por: Ginns, Edward I., et al.
Publicado: (2021)

Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases
por: Chen, Yue-hong, et al.
Publicado: (2022)

Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice
por: Wang, Chao, et al.
Publicado: (2019)

Heat shock protein gene expression and survival in critical illness
por: Villar, Jesús
Publicado: (2000)

Tracking the Activation of Heat Shock Signaling in Cellular Protection and Damage
por: Torii, Shisui, et al.
Publicado: (2022)

Heat Shock Gene Inactivation and Protein Aggregation with Links to Chronic Diseases
por: Martins, Ian James
Publicado: (2018)

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
por: Kedariti, Maria, et al.
Publicado: (2022)

Induction of Heat Shock Proteins in the Therapy of Type 2 Diabetes and Metabolic Syndrome
por: Hooper, Philip L.
Publicado: (2014)

Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis?
por: Bachelez, Hervé
Publicado: (2022)

Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET
por: Collier, T. Lee, et al.
Publicado: (2017)

Crossing the gates of Babylon: Brain-penetrating enzyme replacement for lysosomal disorders
por: Baldo, Guilherme
Publicado: (2023)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
por: Fu, Wenyu, et al.
Publicado: (2020)

Brain Shock—Toward Pathophysiologic Phenotyping in Traumatic Brain Injury
por: Lazaridis, Christos
Publicado: (2022)

The heat shock factor HSF1 juggles protein quality control and metabolic regulation
por: Cantó, Carles
Publicado: (2017)

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease
por: Sun, Ying, et al.
Publicado: (2020)

Dermal fibroblasts from patients with Parkinson’s disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
por: Collins, Lucy M, et al.
Publicado: (2018)

Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
por: Davighi, Maria Giulia, et al.
Publicado: (2020)

Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients
por: Pandey, Manoj Kumar
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6nh4n1tprfs956arjbm1autbbt